Roth Capital analyst Matt Koranda raised the firm’s price target on Standex (SXI) to $260 from $205 and keeps a Buy rating on the shares. The company delivered another healthy quarter, with Q1 highlighted by sustained growth and margin strength at Amran/Narayan, the analyst tells investors in a research note. Core Electronics growth appears to be picking up, and Roth is forecasting mid-single-digit organic growth for the remainder of FY26, supported by a greater than 1x book-to-bill rate, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SXI:
- Standex International: Strong Performance and Promising Growth Prospects Drive Buy Rating
- Standex International Holds Annual Stockholders Meeting
- Standex reports Q1 adjusted EPS $1.99, consensus $1.70
- Standex sees ‘significantly higher revenue’ in Q2
- Standex raises FY26 revenue outlook to over $11M over FY25